
    
      The study will include 30 relapse-remitting multiple sclerosis patients. Assessments of heart
      rate variability and myocardial ventricular repolarisation pattern will be done 1) before
      fingolimod, 2) first day of fingolimod 3) after 3 months use and 4) after 12 months use of
      fingolimod.
    
  